Objectively Measured Physical Activity in Patients with COPD: Recommendations from an International Task Force on Physical Activity.

Physical activity accelerometery methodology standardization

Journal

Chronic obstructive pulmonary diseases (Miami, Fla.)
ISSN: 2372-952X
Titre abrégé: Chronic Obstr Pulm Dis
Pays: United States
ID NLM: 101635411

Informations de publication

Date de publication:
28 Oct 2021
Historique:
pubmed: 26 8 2021
medline: 26 8 2021
entrez: 25 8 2021
Statut: ppublish

Résumé

Physical activity (PA) is of key importance for health among healthy persons and individuals with chronic obstructive pulmonary disease (COPD). PA has multiple dimensions that can be assessed and quantified objectively using activity monitors. Moreover, as shown in the published literature, variable methodologies have been used to date to quantify PA among individuals with COPD, precluding clear comparisons of outcomes across studies. The present paper aims to provide a summary of the available literature for the rationale behind using objectively measured PA and proposes a standardized methodology for assessment, including standard operating procedures for future research. The present paper, therefore, describes the concept of PA, reports on the importance of PA, summarizes the dimensions of PA, provides a standard operating procedure on how to monitor PA using objective assessments, and describes the psychometric properties of objectively measured PA. The present international task force recommends implementation of the standard operating procedure for PA data collection and reporting in the future. This should further clarify the relationship between PA and clinical outcomes, test the impact of treatment interventions on PA in individuals with COPD, and successfully propose a PA endpoint for regulatory qualification in the future.

Identifiants

DOI: 10.15326/jcopdf.2021.0213 PMID: 34433239 PMC: PMC8686852
pubmed: 34433239
doi: 10.15326/jcopdf.2021.0213
pmc: PMC8686852
doi:

Types de publication

Journal Article

Langues

eng

Pagination

528-550

Subventions

Organisme : AstraZeneca
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL151452
Pays : United States
Organisme : GlaxoSmithKline
Pays : United States
Organisme : Chiesi
Pays : United States
Organisme : Boehringer Ingelheim
Pays : United States
Organisme : NICHD NIH HHS
ID : P50 HD098593
Pays : United States

Informations de copyright

JCOPDF © 2021.

Références

Eur Respir J. 2009 Feb;33(2):262-72
pubmed: 19010994
Am J Respir Crit Care Med. 2015 Aug 1;192(3):295-306
pubmed: 26020495
Thorax. 2013 Oct;68(10):962-3
pubmed: 23604460
Int J Chron Obstruct Pulmon Dis. 2019 Sep 03;14:1979-1992
pubmed: 31564846
Eur Respir J. 2013 Oct;42(4):993-1002
pubmed: 23258786
Appl Physiol Nutr Metab. 2013 Feb;38(2):100-14
pubmed: 23438219
PLoS One. 2020 Aug 4;15(8):e0236676
pubmed: 32750073
Circulation. 2008 Aug 19;118(8):800-7
pubmed: 18678768
Respir Med. 2010 Feb;104(2):159-65
pubmed: 19818590
Med Sci Sports Exerc. 2011 Aug;43(8):1575-81
pubmed: 21681120
ANS Adv Nurs Sci. 1996 Mar;18(3):77-89
pubmed: 8660014
Health Qual Life Outcomes. 2012 Mar 13;10:28
pubmed: 22414164
Contemp Clin Trials. 2016 Mar;47:172-84
pubmed: 26806669
Respirology. 2019 Jul;24(7):652-657
pubmed: 30845363
Eur Respir J. 2015 Oct;46(4):988-1000
pubmed: 26022965
Eur Respir Rev. 2019 Nov 13;28(154):
pubmed: 31722891
J Am Heart Assoc. 2018 Mar 22;7(6):
pubmed: 29567764
J Sci Med Sport. 2018 Feb;21(2):166-172
pubmed: 29110991
Am J Respir Crit Care Med. 2005 May 1;171(9):972-7
pubmed: 15665324
Chest. 2014 Aug;146(2):318-327
pubmed: 24603844
Eur Respir J. 2014 Dec;44(6):1521-37
pubmed: 25359358
Lancet. 2012 Jul 21;380(9838):258-71
pubmed: 22818938
Respir Med. 2012 Jul;106(7):962-9
pubmed: 22521225
PLoS One. 2012;7(6):e39198
pubmed: 22745715
Eur Respir J. 2014 Nov;44(5):1223-33
pubmed: 25034563
Neuromuscul Disord. 2019 Jul;29(7):514-516
pubmed: 31272741
Lancet. 2012 Jul 21;380(9838):219-29
pubmed: 22818936
Am J Health Promot. 2018 Nov;32(8):1671-1678
pubmed: 29558811
Prim Care Respir J. 2009 Sep;18(3):208-15
pubmed: 19690787
BMJ. 2019 Aug 21;366:l4570
pubmed: 31434697
Health Qual Life Outcomes. 2011 Dec 20;9:116
pubmed: 22185607
Eur Respir J. 2018 Oct 18;52(4):
pubmed: 30166322
J Am Med Dir Assoc. 2012 Mar;13(3):284-90
pubmed: 21450242
JAMA Intern Med. 2019 Aug 1;179(8):1105-1112
pubmed: 31141585
Thorax. 2018 Apr;73(4):376-384
pubmed: 29306902
PLoS One. 2013 Dec 20;8(12):e84365
pubmed: 24376804
Ann Intern Med. 2006 Jan 17;144(2):73-81
pubmed: 16418406
Clin Sci (Lond). 2010 Feb 09;118(9):565-72
pubmed: 20132099
Int J Chron Obstruct Pulmon Dis. 2016 Jun 10;11:1287-95
pubmed: 27354787
Int J Chron Obstruct Pulmon Dis. 2017 Mar 28;12:1019-1031
pubmed: 28405162
J Physiother. 2012;58(3):189-95
pubmed: 22884186
Health Qual Life Outcomes. 2003 Apr 28;1:13
pubmed: 12773199
Lancet. 2016 Sep 24;388(10051):1302-10
pubmed: 27475271
Am J Respir Crit Care Med. 2007 Mar 1;175(5):458-63
pubmed: 17158282
Chron Respir Dis. 2017 Aug;14(3):256-269
pubmed: 28774199
COPD. 2018 Oct;15(5):432-438
pubmed: 30822241
Chron Respir Dis. 2019 Jan-Dec;16:1479973118816424
pubmed: 30789017
Int J Behav Nutr Phys Act. 2012 Jul 09;9:84
pubmed: 22776399
BMJ Open Respir Res. 2019 Feb 18;6(1):e000350
pubmed: 30956796
COPD. 2013 Jun;10(3):367-77
pubmed: 23713597
Thorax. 2017 May;72(5):415-423
pubmed: 28137918
Chest. 2011 Aug;140(2):331-342
pubmed: 21273294
JAMA Intern Med. 2016 Jun 1;176(6):816-25
pubmed: 27183032
COPD. 2017 Jun;14(3):276-283
pubmed: 28388284
Public Health Rep. 1985 Mar-Apr;100(2):126-31
pubmed: 3920711
Respir Care. 2017 May;62(5):579-587
pubmed: 28270544
Respiration. 2014;88(2):92-100
pubmed: 24851826
Sensors (Basel). 2018 Apr 15;18(4):
pubmed: 29662048
JAMA. 2018 Nov 20;320(19):2020-2028
pubmed: 30418471
JAMA. 1989 Nov 3;262(17):2395-401
pubmed: 2795824
Chest. 2012 Aug;142(2):338-346
pubmed: 22281798
PLoS One. 2016 Apr 28;11(4):e0154587
pubmed: 27124297
Eur Respir J. 2012 Nov;40(5):1115-22
pubmed: 22362854
Thorax. 2021 Mar;76(3):228-238
pubmed: 33479044
Med Sci Sports Exerc. 2019 May;51(5):833-840
pubmed: 30531289
PLoS One. 2017 Feb 1;12(2):e0169649
pubmed: 28146576
J Sci Med Sport. 2017 Aug;20(8):761-765
pubmed: 28159535
Thorax. 2014 Aug;69(8):731-9
pubmed: 24558112
Respir Res. 2013 Oct 30;14:115
pubmed: 24229341
Med Sci Sports Exerc. 2012 Jan;44(1 Suppl 1):S68-76
pubmed: 22157777
Lancet. 2016 Sep 24;388(10051):1325-36
pubmed: 27475270
Eur Respir J. 2013 Nov;42(5):1205-15
pubmed: 23397303

Auteurs

Heleen Demeyer (H)

Department of Rehabilitation Sciences, KU Leuven-University of Leuven and Respiratory Division, University Hospitals Leuven, Leuven, Belgium.
Department of Rehabilitation Sciences, Ghent University, Ghent, Belgium.

Divya Mohan (D)

Medical Innovation, Value Evidence and Outcomes, GlaxoSmithKline Research and Development, Collegeville, Pennsylvania, United States.

Chris Burtin (C)

Reval Rehabilitation Research Center, Biomed Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.

Anouk W Vaes (AW)

Department of Research and Development, CIRO, Horn, Netherlands.

Matthew Heasley (M)

Digital Biomarkers, GlaxoSmithKline Research and Development, Stevenage, United Kingdom.

Russell P Bowler (RP)

National Jewish Health, Denver, Colorado, United States.

Richard Casaburi (R)

Rehabilitation Clinical Trials Center, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, United States.

Christopher B Cooper (CB)

Departments of Medicine and Physiology, David Geffen School of Medicine, University of California, Los Angeles, California, United States.

Solange Corriol-Rohou (S)

AstraZeneca Research and Development, Global Regulatory Excellence, Paris, France.

Anja Frei (A)

Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.

Alan Hamilton (A)

Boehringer Ingelheim Canada, Burlington, Ontario, Canada.

Nicholas S Hopkinson (NS)

National Heart and Lung Institute, Imperial College, London, United Kingdom.
Respiratory Medicine, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom.

Niklas Karlsson (N)

BioPharmaceuticals Research and Development Digital Health, AstraZeneca, Gothenburg, Sweden.

William D-C Man (WD)

National Heart and Lung Institute, Imperial College, London, United Kingdom.
Harefield Respiratory Research Group, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom.

Marilyn L Moy (ML)

Pulmonary, Critical Care, and Sleep Medicine Section, VA Boston Healthcare System, Boston, Massachusetts, United States.
Harvard Medical School, Boston, Massachusetts, United States.

Fabio Pitta (F)

Laboratory of Research in Respiratory Physiotherapy, State University of Londrina, Brazil.

Michael I Polkey (MI)

National Heart and Lung Institute, Imperial College, London, United Kingdom.
Respiratory Medicine, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom.

Milo Puhan (M)

Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.

Stephen I Rennard (SI)

Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, United States.

Carolyn L Rochester (CL)

Section of Pulmonary, Critical Care and Sleep, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States.
VA Connecticut Healthcare System, West Haven, Connecticut, United States.

Harry B Rossiter (HB)

Rehabilitation Clinical Trials Center, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, United States.
Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom.

Frank Sciurba (F)

Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pennsylvania, United States.

Sally Singh (S)

Department of Respiratory Science, University of Leicester, Leicester, United Kingdom.

Ruth Tal-Singer (R)

COPD Foundation, COPD360 Research, Miami, Florida, United States.

Ioannis Vogiatzis (I)

Department of Sport, Exercise, and Rehabilitation, Northumbria University, Newcastle, United Kingdom.

Henrik Watz (H)

Pulmonary Research Institute at LungenClinic Grosshansdorf, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany.

Rob Van Lummel (RV)

McRoberts B.V., The Hague, Netherlands.

Jeremy Wyatt (J)

ActiGraph, LLC, Pensacola, Florida, United States.

Debora D Merrill (DD)

COPD Foundation, COPD360 Research, Miami, Florida, United States.

Martijn A Spruit (MA)

Reval Rehabilitation Research Center, Biomed Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
Department of Research and Development, CIRO, Horn, Netherlands.
Department of Respiratory Medicine, School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre, Maastricht, Netherlands.

Judith Garcia-Aymerich (J)

ISGlobal, Barcelona, Spain.
Universitat Pompeu Fabra, Barcelona, Spain.
CIBER Epidemiología y Salud Pública, Madrid, Spain.

Thierry Troosters (T)

Department of Rehabilitation Sciences, KU Leuven-University of Leuven and Respiratory Division, University Hospitals Leuven, Leuven, Belgium.

Classifications MeSH